[Glucose intolerance in liver diseases].
Aoki
Yuji
Y
Second Department of Internal Medicine, Shinshu University School of Medicine.
D001629:Bezafibrate / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000209:etiology; D018149:Glucose Intolerance / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007333:Insulin Resistance; D008107:Liver Diseases / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology
D000960:Hypolipidemic Agents; D001629:Bezafibrate